Replies to post #3 on Instadose Pharma Corp (INSD)

[Big Brother]

idk....Hard to say, depends on what it is I guess. If it's Instadose, according to the CEO, it will have more revenue and more EBITDA, than any startup company ever in Canadian history, and will be the largest cannabis growers on Earth.....now whether or not that hyperbole, or what, I don't know.

At this point, there has only been a change in management, not a change in control, as far as we know, so have to watch for a name change, or shares changing hands to get a better idea what's up.

Of course, as you know, PAUL typically shows up on new issue tickers, that run big, or get a lot of volume, so that in itself makes it one to put on high alert.

[Big Brother]

From what I gather, I believe they raised at least $5M in a private placement done @ $2.00, this was from early 2019, so I would think starting pps would maybe be in the $2.00 - $3.00 range.

Dear shareholders and interested investors,

My name is Grant F. Sanders and I am the new Chairman & Chief Executive Officer of Instadose Pharma Corp. (“Instadose”), formerly Excellence Health Group Inc. (“EHG”). In February 2019, EHG completed a share exchange transaction (the “Transaction”) with IDP Holdings Inc. making EHG the "soon-to-be" largest producer and distributor of cannabinoid oil in the world. With the Transaction now complete, and with a new name, Instadose has now commenced the process to list publicly on the Canadian Securities Exchange.

For the better part of the past decade, I have been deeply engaged in establishing strong relations with the government of The Democratic Republic of the Congo (the “DRC”) on a number of levels, most relevant of which has been securing the exclusive right and license to produce, cultivate, and process medical/pharmaceutical cannabis into cannabinoid oil for world-wide export and sale. In partnership with both the DRC government and the DRC’s largest registered farming co-operative, we have secured exclusive rights over 1,000,000+ hectares of land strictly dedicated for cannabis and cannabinoid oil production. To understand the scale of this endeavour, Canada’s largest licensed producer, Canopy Growth Corp., has approximately 40 hectares of total production land. That puts Instadose Pharma at 250x Canada’s largest producer. To date, Instadose Pharma is in receipt of oil supply agreements exceeding $4.375 Billion over a five-year period with many more such agreements in the pipeline. We are now only months away from forever changing the cannabis/cannabinoid oil industry with our first cannabis crop in the DRC expected to be harvested and processed into cannabinoid oil for sale by August 2019. With this very first crop, we will have achieved our goal of market disruption by creating the industry’s greatest commercial production capacity for cannabinoid oil at an industry-shattering production cost.

Included with this letter to you is a copy of Instadose’s most recent company presentation explaining exactly how we have arrived at where we are today (link: Instadose Pharma Corporate Presentation). It outlines our process of turning cannabis and cannabinoid oil into insurable commodities and provides you with a strong production and cost comparison between Instadose and other Canadian producers. Finally, it details our level of government support, and our visions for the future including our projected company valuation.

Joining me at Instadose Pharma will be a familiar face in Dr. Luc Duchesne who will continue to serve our company as the Chief Science Officer. Dr. Luc Duchesne has been on the ground with me in the DRC for a significant period of time since the completion of the Transaction. He has selected Congolese landraces and gathered a total of 76 kg of seeds which will equate to 200 hectares of plants for production and cloning. He has trained African growers and initially planted over 20,000 seeds in various trials on three sites which led to the development of a custom grow process that matches the African climate, latitude and soils to optimize cannabis yields. This will enable us to produce, cultivate, and process cannabis and cannabinoid oil on the first 10,000 hectares of land accessible to us in the DRC over the next 1-2 years.

Dr. Luc Duchesne will also be joined by Dr. Douglas K. Macfadden who will serve our company as Chief Medical Officer. With a strong core of experienced management in place, we will now look to build out our team to include a number of world-renowned experts to help guide us through our coming years.

Final Private Placement

Instadose is now in the late stages of completing a final private placement at $2.00 per common share (the “Private Placement”). The opportunity to participate is open to all of you until Friday April 5, 2019, should you wish to do so before we complete our public listing. We expect our final prospectus to be a non-offering prospectus whereby we simply qualify the company’s common shares and special warrants for trading. Should you wish to improve your equity position, this is your final opportunity to do so (link: $2.00 Subscription Agreement).

Health Canada License

In January, after weeks of silence, Health Canada contacted us to clarify a few final points which we then sufficiently addressed. Today, we are simply in waiting mode for the license to be issued. We will update you as soon as this has happened.

Investor Communication

Should you wish to contact us with questions about the Transaction, Instadose’s business model, or with an interest in participating in the Private Placement, you are free to contact Instadose’s Chief Legal Officer, Loren S. Greenspoon, by email at [e-mail]. We also wish to turn your attention to the company’s new website which is now available for viewing on-line at www.instadosepharma.com.

We appreciate your patience throughout this process and we thank you for your continued support. We will continue to update you regularly throughout the coming months and look forward to sharing the news of our public listing with you.

Sincerely,


Grant F. Sanders
Chairman & Chief Executive Officer
Instadose Pharma Corp.

[Big Brother]

Merger could be completed within the next 3 weeks, however, with only 5K shares held @ DTC, there is nothing for anyone to buy at this point, and it could potentially be a challenge to get a clearing firm to accept deposits with 25M unrestricted.

I'd think you would want maybe 100K in there at minimum on a stock like this, maybe even 200K - 250K would be better, as the 8K and subsequent PR's should attract a lot of attention.

https://www.otcmarkets.com/stock/MZKR/security

[Big Brother]

PAUL completely gone off L2 again, that's the 2nd time now.